U.S., March 24 -- ClinicalTrials.gov registry received information related to the study (NCT07487766) titled 'The Safety and Efficacy of XytriX in the Treatment of Knee Osteoarthritis' on March 17.
Brief Summary: This study aims to study the safety and efficacy of XytriX, an umbilical cord-derived stem cell product, in the treatment of knee osteoarthritis.
Study Start Date: May, 2026
Study Type: INTERVENTIONAL
Condition:
Osteoarthritis
Intervention:
DRUG: XytriX, umbilical cord-derived mesenchymal stem cell
There are no other interventions in this study.
Recruitment Status: NOT_YET_RECRUITING
Sponsor: TricelX Inc.
Published by HT Digital Content Services with permission from Health Daily Digest....